| Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers (NCT05884320) | M.D. Anderson Cancer Center | 2023-07-27 |
| A Clinical Study to Evaluate the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Received Three or More Lines of Therapy (NCT05998928) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2023-07-27 |
| Mindfulness-based Cognitive Coping for ADRD Caregivers (NCT05979922) | Photozig, Inc. | 2023-07-27 |
| TSN222 in Subjects With Advanced Solid Tumors or Lymphomas (NCT05842785) | Tyligand Bioscience (Shanghai) Limited | 2023-07-26 |
| Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer (NCT05949541) | Fudan University | 2023-07-26 |
| A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age (NCT05975099) | ModernaTX, Inc. | 2023-07-26 |
| Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis (NCT05971602) | Gates Medical Research Institute | 2023-07-26 |
| PREventing Second Cancers With DOSTARlimab (NCT05855811) | Centre Leon Berard | 2023-07-26 |
| A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular Typing (NCT05924256) | Fudan University | 2023-07-26 |
| Effect of Acetaminophen Preemptive Analgesia on Postoperative Cognitive Function (NCT06004687) | Affiliated Hospital of Nantong University | 2023-07-26 |
| Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer (NCT05696782) | Wake Forest University Health Sciences | 2023-07-26 |
| A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A (NCT06185335) | Biocad | 2023-07-26 |
| pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer (NCT05799144) | Michael K. Gibson | 2023-07-26 |
| RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms (NCT05965726) | Kanecia Obie Zimmerman | 2023-07-26 |
| Interoception and Body Scan (NCT06237530) | University of Valencia | 2023-07-26 |
| Aspirin for Postpartum Patients With Preeclampsia (NCT05924971) | MemorialCare Health System | 2023-07-26 |
| Savolitinib Plus Docetaxel as 2L in EGFR/ALK/ROS1/MET ex14m-wildtype NSCLC With MET Overexpression (NCT05777278) | The First Affiliated Hospital of Guangzhou Medical University | 2023-07-26 |
| RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms (NCT05595369) | Kanecia Obie Zimmerman | 2023-07-26 |
| The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLC (NCT06139419) | Sun Yat-sen University | 2023-07-25 |
| A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression. (NCT05845138) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2023-07-25 |
| CD40L Antagonism in Rheumatoid Arthritis (RA) (NCT05306353) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-07-25 |
| A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia (NCT05955261) | St. Jude Children's Research Hospital | 2023-07-25 |
| A Novel, Potent and Non-addictive Analgesic of Combinations for Knee Replacement Moderate to Severe Pain Management (NCT05842733) | Sinew Pharma Inc. | 2023-07-25 |
| Study of the Selective GlyT1 Inhibitor Bitopertin for Steroid-Refractory Diamond-Blackfan Anemia (NCT05828108) | National Heart, Lung, and Blood Institute (NHLBI) | 2023-07-25 |
| Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy (NCT04691817) | Abramson Cancer Center at Penn Medicine | 2023-07-25 |
| Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM (NCT06005012) | University of California, San Diego | 2023-07-25 |
| A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies (NCT05955105) | Innolake Biopharm | 2023-07-25 |
| Homologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine (NCT05933278) | PT Bio Farma | 2023-07-25 |
| A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS) (NCT05798520) | Biogen | 2023-07-25 |
| Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease (NCT05910528) | Hoffmann-La Roche | 2023-07-24 |
| Adjunctive Treatment for Chronic Rhinosinusitis With Nasal Polyposis (NCT03607175) | Marina Boruk | 2023-07-24 |
| Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120) (NCT05835466) | Icahn School of Medicine at Mount Sinai | 2023-07-24 |
| A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies (NCT05473156) | AP Biosciences Inc. | 2023-07-24 |
| Olvi-Vec Combined With Platinum Plus Etoposide Therapy in Patients With Late Phase SCLC (NCT07136285) | Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd. | 2023-07-24 |
| A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease (NCT06015841) | AC Immune SA | 2023-07-24 |
| Washed Microbiota Transplantation for Chronic Constipation in Adults (NCT06106685) | The Second Hospital of Nanjing Medical University | 2023-07-24 |
| Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer (NCT05748834) | SCRI Development Innovations, LLC | 2023-07-24 |
| Effect of MgSO4 Pretreatment on Muscle Relaxation (NCT05757999) | Assiut University | 2023-07-23 |
| Tissue Inhibitor of Metalloproteinases 2 Level in Patients Undergoing Cardiac Surgery (NCT06871826) | Wuhan University | 2023-07-22 |
| Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia (NCT05776004) | Eagle Pharmaceuticals, Inc. | 2023-07-22 |
| Study of MAR001 in Adults With Metabolic Dysfunction (NCT05896254) | Marea Therapeutics | 2023-07-22 |
| Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation (NCT05873205) | Memorial Sloan Kettering Cancer Center | 2023-07-21 |
| Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare (NCT05936268) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2023-07-21 |
| Evaluation of AUP12602-C as New Topical Treatment for DFUs (DIAMEND STUDY) (NCT06111183) | Aurealis Oy | 2023-07-21 |
| Front-line VenObi Combination Followed by Ven or VenZan Combination in Patients With Residual Disease: a MRD Tailored Treatment for Young Patients With High-risk CLL (NCT05478512) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2023-07-21 |
| MLC1501 Study Assessing Efficacy in Post STrOke Subjects With mOtor Deficits (NCT05289947) | Moleac Pte Ltd. | 2023-07-21 |
| A Phase Ⅱ Study Assessing the Safety and Efficacy of PLB1004 in EGFR ex20ins Mutation Patients With Advanced and Metastatic Non-small Cell Lung Cancer(NSCLC) (NCT06015503) | Avistone Biotechnology Co., Ltd. | 2023-07-21 |
| Effects of Early Testosterone Gel Administration on Physical Performance in the Critically Ill (NCT05825092) | University Hospital, Clermont-Ferrand | 2023-07-21 |
| A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP) (NCT05714969) | Takeda | 2023-07-21 |
| A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes (NCT05936151) | Eli Lilly and Company | 2023-07-20 |
| Comparative Analysis of the Lung Inflammatory Response After Thoracic Surgery With Single or Double Lung Ventilation: a Randomized, Pilot, Trial (NCT05982639) | Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude | 2023-07-20 |
| DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUC (NCT06354231) | Fudan University | 2023-07-20 |
| Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants (NCT06676410) | Code Pharma | 2023-07-20 |
| A Phase 2 Trial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate Cancer (NCT05900973) | D'Or Institute for Research and Education | 2023-07-20 |
| Prospective Clinical Study of ZPR Regimen in Elderly Treatment-naive Diffuse Large B-cell Lymphoma (NCT05940064) | Peng Liu | 2023-07-20 |
| ONS in Gastrointestinal Cancer Patients Undergoing Chemotherapy (NCT05980624) | Beni-Suef University | 2023-07-20 |
| A Study of AK0529 in Adults Patients Hospitalized With RSV Infection (NCT06942299) | Shanghai Ark Biopharmaceutical Co., Ltd. | 2023-07-20 |
| Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10% (NCT05659563) | MedSIR | 2023-07-20 |
| Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy (NCT05834738) | Novartis Pharmaceuticals | 2023-07-20 |
| Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis (NCT05997927) | Jiangsu vcare pharmaceutical technology co., LTD | 2023-07-20 |
| Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer (NCT05983107) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2023-07-20 |
| AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1) (NCT05850234) | AstraZeneca | 2023-07-20 |
| Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers (NCT05669664) | National Cancer Institute (NCI) | 2023-07-20 |
| A Study to Explore the Third-line Treatment of Fruquintinib Combined With Serplulimab in Advanced Non-liver-limited Metastatic Colorectal Cancer: a Single-center, Phase 2 Study (NCT05954429) | Fudan University | 2023-07-20 |
| The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias (NCT05756322) | Lin BioScience, Inc | 2023-07-20 |
| A Study of the Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering TherapyUrate-lowering (GenSci048-202) (NCT05936281) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2023-07-20 |
| Modified Atkins Diet Versus Topiramate In Children With Epileptic Spasms Refractory To Hormonal Treatment: A Randomized Open-Label Study (NCT05958160) | Lady Hardinge Medical College | 2023-07-20 |
| Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma (NCT06138769) | Asan Medical Center | 2023-07-20 |
| The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer Patients (NCT05944809) | JIANYANG WANG | 2023-07-20 |
| Prospective Clinical Study of ZPR Regimen in Relapsed/Refractory Diffuse Large B-cell Lymphoma (NCT05940051) | Peng Liu | 2023-07-20 |
| Long-term Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Ulcerative Colitis (NCT07154784) | Seoul National University Hospital | 2023-07-19 |
| Assessment of the Safety and Efficacy of C019199 Plus Sintilimab in Participants With Advanced Solid Tumors (NCT06220318) | Fujian Haixi Pharmaceuticals Co., Ltd. | 2023-07-19 |
| A Study of BL-B01D1 and BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NCT05880706) | Sichuan Baili Pharmaceutical Co., Ltd. | 2023-07-19 |
| Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors (NCT05639933) | Hoth Therapeutics, Inc. | 2023-07-19 |
| A Study of RC88 Combined With Sintilimab for Advanced Solid Tumours (NCT05804526) | RemeGen Co., Ltd. | 2023-07-19 |
| Neoadjuvant Cadonilimab in Combination With Cisplatin and Nab-paclitaxel in Resectable Head and Neck Squamous Cell Carcinoma (NCT06023875) | Xuekui Liu | 2023-07-19 |
| PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular Rosacea (NCT06013371) | Icahn School of Medicine at Mount Sinai | 2023-07-19 |
| PRISM Race and Communication Pilot RCT (NCT04915079) | University of Washington | 2023-07-19 |
| MIrabegron and Physiological Function in Cold Environments (NCT05990387) | Indiana University | 2023-07-19 |
| Safety and Efficacy Study of Transplantation of Autologous CD34+ Cells Transduced With the G2ARTE Lentiviral Vector Expressing the DCLRE1C cDNA in Artemis (DCLRE1C) Deficient Severe Combined Immunodeficiency Patients (ARTEGENE) (NCT05071222) | Assistance Publique - Hôpitaux de Paris | 2023-07-19 |
| Safety and Efficacy Study of GB001 Recombinant Peptide Spray in Subjects With Mild Recurrent Aphthous Ulcers (NCT06429566) | Zhejiang Echon Biopharm Limited | 2023-07-18 |
| Treatment of Hypopigmented Scars With Bimatoprost (NCT06122090) | Medstar Health Research Institute | 2023-07-18 |
| Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma (NCT05783596) | Reid Merryman, MD | 2023-07-18 |
| A Study of HB0045 Injection in Patients With Advanced Solid Tumors (NCT06056323) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2023-07-18 |
| Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography. (NCT06111872) | National University of Malaysia | 2023-07-18 |
| CBD (Cannabidiol) Intraoral Application and TMD (Temporomandibular Disorders) (NCT05562635) | Medical University of Silesia | 2023-07-18 |
| RC48 Plus Tislelizumab, Low-dose Capecitabine and Celecoxib for HER2-positive Metastatic Colorectal Cancer (NCT05578287) | Sun Yat-sen University | 2023-07-18 |
| Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer (NCT04975516) | Mayo Clinic | 2023-07-18 |
| Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma (NCT06126510) | CNBG-Virogin Biotech (Shanghai) Ltd. | 2023-07-18 |
| Clinical Trial to Explore the Skin Test Dosage of EEC in People Aged 18 to 65 Years Old and the Safety and Preliminary Efficacy in People Aged 3 to 75 Years Old. (NCT06305104) | Chengdu CoenBiotech Co., Ltd | 2023-07-18 |
| A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations (NCT05801029) | AstraZeneca | 2023-07-18 |
| A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer (NCT05852691) | Hoffmann-La Roche | 2023-07-18 |
| CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease (NCT06347718) | Miltenyi Biomedicine GmbH | 2023-07-17 |
| Pembrolizumab in Combination With Eftilagimod Alpha and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcoma - EFTISARC-NEO Trial (NCT06128863) | Maria Sklodowska-Curie National Research Institute of Oncology | 2023-07-17 |
| A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction (NCT05806138) | Memorial Sloan Kettering Cancer Center | 2023-07-17 |
| Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease (NCT05067621) | Yale University | 2023-07-17 |
| Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors (NCT05746208) | University of California, San Francisco | 2023-07-17 |
| Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer (NCT05797831) | Kartos Therapeutics, Inc. | 2023-07-17 |
| Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations (NCT05845671) | University of Colorado, Denver | 2023-07-17 |
| Patient-Customized Bioprinting Technology for Practical Regeneration of the Respiratory Tract (Trachea) (NCT06051747) | Ja Seong Bae, MD, phD | 2023-07-17 |